CHELSEA POSS: Open Payments
NPI 1770256265 · TANNER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 40 payments from 13 companies in 2025. Trend: 2023 $265 · 2024 $1,134 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $145 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Lilly USA, LLC | 3 | $71 |
| Novo Nordisk Inc | 3 | $62 |
| PFIZER INC. | 3 | $48 |
| Exact Sciences Corporation | 2 | $45 |
| Lundbeck LLC | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Amgen Inc. | 2 | $33 |
Products named: VRAYLAR, MOUNJARO, AIRSUPRA, NURTEC ODT, Cologuard Collection Kit, Wegovy, TRINTELLIX, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
